VOYA Investment Management
MRNA icon

VOYA Investment Management’s Moderna MRNA Stock Holding History

VOYA Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.3M Sell
439,076
-17,364
-4% -$810K 0.02% 450
2025
Q4 		$13.5M Buy
456,440
+343,604
+305% +$9.34M 0.01% 584
2025
Q3 		$2.91M Sell
112,836
-57,850
-34% -$1.61M ﹤0.01% 1085
2025
Q2 		$4.71M Buy
170,686
+35,379
+26% +$932K ﹤0.01% 977
2025
Q1 		$3.84M Sell
135,307
-14,585
-10% -$518K ﹤0.01% 1050
2024
Q4 		$6.23M Sell
149,892
-2,523
-2% -$121K 0.01% 897
2024
Q3 		$10.2M Sell
152,415
-58,267
-28% -$5.35M 0.01% 757
2024
Q2 		$25M Sell
210,682
-37,737
-15% -$4.78M 0.02% 471
2024
Q1 		$26.5M Sell
248,419
-211,452
-46% -$21.3M 0.03% 465
2023
Q4 		$45.7M Buy
459,871
+149,929
+48% +$12.6M 0.05% 357
2023
Q3 		$32M Sell
309,942
-215,899
-41% -$24.1M 0.04% 407
2023
Q2 		$63.9M Buy
525,841
+43,799
+9% +$5.84M 0.07% 286
2023
Q1 		$74M Sell
482,042
-4,759
-1% -$785K 0.08% 279
2022
Q4 		$87.4M Sell
486,801
-148,317
-23% -$24.3M 0.1% 243
2022
Q3 		$75.1M Buy
635,118
+493,193
+348% +$74.8M 0.09% 257
2022
Q2 		$20.3M Buy
141,925
+2,475
+2% +$354K 0.05% 311
2022
Q1 		$24M Sell
139,450
-13,328
-9% -$2.24M 0.05% 304
2021
Q4 		$38.8M Buy
152,778
+27,459
+22% +$8.03M 0.07% 226
2021
Q3 		$48.2M Buy
125,319
+80,629
+180% +$29.7M 0.1% 194
2021
Q2 		$10.5M Sell
44,690
-49,899
-53% -$8.92M 0.02% 595
2021
Q1 		$12.4M Sell
94,589
-6,167
-6% -$894K 0.03% 493
2020
Q4 		$10.5M Sell
100,756
-5,192
-5% -$525K 0.02% 554
2020
Q3 		$7.5M Buy
105,948
+2,267
+2% +$158K 0.02% 612
2020
Q2 		$6.66M Buy
103,681
+27,832
+37% +$1.52M 0.02% 656
2020
Q1 		$2.27M Buy
75,849
+3,696
+5% +$85K 0.01% 906
2019
Q4 		$1.41M Buy
72,153
+17,983
+33% +$319K ﹤0.01% 1258
2019
Q3 		$862K Buy
+54,170
New +$800K ﹤0.01% 1413

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VOYA Investment Management's MRNA Position: Q1 2026 in Review

VOYA Investment Management reduced its Moderna (MRNA) stake by 3.8% in Q1 2026, selling an estimated $810K and leaving 439,076 shares worth $22.3M. The position accounts for 0.02% of the portfolio, ranked #450.

VOYA Investment Management first reported a position in MRNA in Q3 2019 and has held it in 27 quarters since. The position peaked at $87.4M in Q4 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • VOYA Investment Management held 439,076 shares of Moderna worth $22.3M as of Q1 2026.
  • VOYA Investment Management sold 17,364 Moderna shares in Q1 2026, an estimated $810K.
  • Moderna made up 0.02% of VOYA Investment Management's portfolio in Q1 2026, its #450 holding.
  • VOYA Investment Management first reported a position in Moderna in Q3 2019 and has held it in 27 quarters since.
  • VOYA Investment Management's Moderna position peaked at $87.4M in Q4 2022.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.